| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.083 | 0.006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.42 | 0.008 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |